Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,104Revenue $M10.8Net Margin (%)-6,286.4Altman Z-Score12.3
Enterprise Value $M935EPS $-1.2Operating Margin %-6,270.1Piotroski F-Score2
P/E(ttm)--Beneish M-Score23.1Pre-tax Margin (%)-6,250.3Higher ROA y-yN
Price/Book6.510-y EBITDA Growth Rate %--Quick Ratio4.8Cash flow > EarningsY
Price/Sales5015-y EBITDA Growth Rate %--Current Ratio5.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-85.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-103.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M104ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2015-03-31 Add0.88%$10.87 - $14.68
($12.86)
$ 10.66-17%Add 22.30%22,380,200
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
($15.32)
$ 10.66-30%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 10.66-25%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 10.66-29%New holding6,310,850
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Tarnok Michael P.Director 2015-05-06Buy10,000$9.734.83view
Adams BrianVP and General Counsel 2015-04-15Sell4,320$12.4-17.74view
Oliviero James F IIICFO 2015-04-06Sell1,878$11.68-12.67view
BENTSUR RONCEO 2015-04-06Sell1,592$11.68-12.67view
Madison GregPresident and COO 2015-03-06Buy6,380$12.53-18.6view
Madison GregPresident and COO 2015-02-09Sell6,759$10.95-6.85view
BENTSUR RONCEO 2015-01-05Sell5,574$13.79-26.03view
Oliviero James F IIICFO 2015-01-05Sell5,604$13.79-26.03view
BENTSUR RONCEO 2014-12-30Sell200,000$14.11-27.71view
BENTSUR RONCEO 2014-12-29Sell338,977$13.98-27.04view

Press Releases about KERX :

    Quarterly/Annual Reports about KERX:

    News about KERX:

    Articles On GuruFocus.com
    my portfolio May 08 2015 
    Analysts Positive on Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data May 05 2015 
    Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 
    Portfolio Feb 16 2015 
    2015 Must-Buys In Biotech Sector Feb 02 2015 
    me Jan 23 2015 
    Seth Klarman Keeps Buying LNG, KERX, PBF And Keeps Selling THRX Dec 05 2014 
    Baupost’s Seth Klarman Buys Cheniere Energy, Ocwen Financial, Antero Resources, Sells Boyd Gaming, Nov 14 2014 
    Seth Klarman’s The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, Sel Aug 14 2014 
    Seth Klarman Tops Guru Scoreboard for First Half 2014 Jul 05 2014 

    More From Other Websites
    CORRECTING and REPLACING -- Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch... May 12 2015
    CORRECTING and REPLACING -- Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch... May 12 2015
    ​A battle brews between Baupost Group and short investors drug firm Keryx May 12 2015
    Keryx Biopharmaceuticals (KERX) Jumps: Stock Up 14.8% - Tale of the Tape May 12 2015
    KERYX BIOPHARMACEUTICALS INC Financials May 08 2015
    Keryx CEO 'pleased' with drug launch as firm expands in Boston May 07 2015
    10-Q for Keryx Biopharmaceuticals, Inc. May 06 2015
    Is Isis just what the doctor ordered? May 06 2015
    Keryx Hits Some Kinks May 06 2015
    Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference May 05 2015
    Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference May 05 2015
    Keryx Biopharmaceuticals Posts In-line Loss, Revenue Beat - Analyst Blog May 05 2015
    The 52-Week Low Club for Monday May 04 2015
    Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today May 04 2015
    Keryx Biopharmaceuticals Announces First Quarter 2015 Financial Results May 04 2015
    Keryx Biopharma reports 1Q loss May 04 2015
    Keryx Biopharma reports 1Q loss May 04 2015
    Keryx Biopharmaceuticals Announces First Quarter 2015 Financial Results May 04 2015
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 04 2015
    Q1 2015 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open May 04 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK